RXO
$25.65
Revenue | $1040Mn |
Net Profits | $-243Mn |
Net Profit Margins | -23.37% |
Rxo Inc’s revenue jumped 6.56% since last year same period to $1040Mn in the Q3 2024. On a quarterly growth basis, Rxo Inc has generated 11.83% jump in its revenue since last 3-months.
Rxo Inc’s net profit fell -24200% since last year same period to $-243Mn in the Q3 2024. On a quarterly growth basis, Rxo Inc has generated -3371.43% fall in its net profits since last 3-months.
Rxo Inc’s net profit margin fell -22704.62% since last year same period to -23.37% in the Q3 2024. On a quarterly growth basis, Rxo Inc has generated -3004.26% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.04 |
EPS Estimate Current Year | 0.04 |
Rxo Inc’s earning per share (EPS) estimates for the current quarter stand at 0.04 - a 100% jump from last quarter’s estimates.
Rxo Inc’s earning per share (EPS) estimates for the current year stand at 0.04.
Earning Per Share (EPS) | 0.05 |
Rxo Inc’s earning per share (EPS) jumped 0% since last year same period to 0.05 in the Q3 2024. This indicates that the Rxo Inc has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-11-07 | 0.04 | 0.05 | 25% |
2024-08-07 | 0.02 | 0.03 | 50% |
2024-05-07 | -0.04 | -0.03 | 25% |